封面
市场调查报告书
商品编码
1291481

医药精细化学品市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Pharmaceutical Fine Chemicals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

市场概况:

全球医药精细化学品市场规模在2022年达到1326亿美元。展望未来,IMARC集团预计到2028年,市场规模将达到1953亿美元,在2023-2028年期间表现出6.42%的增长率(CAGR)。

精细化学品是指一组以较高价格生产的有限数量的纯净和复杂化学品。它们是在多用途工厂中,在多步骤批量生物技术方法的支持下生产的。与特种化学品不同的是,这些物质是根据其独特的功能特点和特定的分子特性精确积累的。在收集之后,精细化学品被用作生产一些医药化工产品的关键剂、稳定剂和溶剂,包括硬脂酸镁和明胶。目前,它们在商业上有专利和非专利的变种。

医药精细化学品市场趋势:

各种神经和心血管疾病,包括心律失常、中风、癌症和冠状动脉疾病,特别是在老年人口中的发病率越来越高,这是推动医药精细化工市场发展的主要因素之一。与此相呼应,一些国家的政府机构为引进新型疫苗、药物和医药药物以抵御冠状病毒疾病(COVID-19)和其他一些疾病而采取的有利倡议,进一步促进了这些药物在医疗保健领域的广泛采用。这反过来又成为该市场的另一个增长诱导因素。此外,在满足质量标准的前提下,利用医药精细化学品作为原料生产药品的不同准则的实施,也促进了市场的增长。其他因素,如制药业的显著扩张,对研究和开发(R&D)活动的投资增加,以及消费者对众多疾病和现有药物选择的认识不断提高,都为全球市场创造了积极的前景。

本报告所回答的关键问题:

  • 迄今为止,全球医药精细化学品市场的表现如何,在未来几年将如何表现?
  • COVID-19对全球医药精细化学品市场的影响是什么?
  • 主要的区域市场是什么?
  • 基于类型的市场细分是什么?
  • 基于产品的市场细分是什么?
  • 基于规模的市场细分是什么?
  • 基于应用的市场细分是什么?
  • 该行业价值链的各个阶段是什么?
  • 该行业的关键驱动因素和挑战是什么?
  • 全球医药精细化学品市场的结构是什么,谁是主要的参与者?
  • 该行业的竞争程度如何?

目录

第一章:前言

第二章:范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:简介

  • 概述
  • 主要行业趋势

第五章:全球医药精细化学品市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章:按类型分類的市场

  • 专有的
    • 市场趋势
    • 市场预测
  • 非专有的
    • 市场趋势
    • 市场预测

第7章 :按产品分類的市场

  • 有效成分
    • 市场趋势
    • 市场预测
  • 基本构件
    • 市场趋势
    • 市场预测
  • 高级中间体
    • 市场趋势
    • 市场预测

第8章:按规模分類的市场

  • 大分子化合物
    • 市场趋势
    • 市场预测
  • 小分子药物
    • 市场趋势
    • 市场预测

第九章:按应用分類的市场

  • 心血管疾病
    • 市场趋势
    • 市场预测
  • 神经系统
    • 市场趋势
    • 市场预测
  • 肿瘤学
    • 市场趋势
    • 市场预测
  • 呼吸系统
    • 市场趋势
    • 市场预测
  • 胃肠道
    • 市场趋势
    • 市场预测
  • 肌肉骨骼类
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第十章:按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十一章 :SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十二章 :价值链分析

第十三章 :波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十四章:价格分析

第十五章 :竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • BASF SE
    • Borregaard ASA
    • CHEMADA Industries Ltd. (Turpaz)
    • Denisco Chemicals Pvt Ltd
    • Dupont De Nemours Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Koninklijke DSM N.V.
    • Lonza Group AG
    • Solvay S.A.
    • Syntor Fine Chemicals Ltd. (Aceto Corporation)
    • W. R. Grace and Co. (Standard Industries Inc.)
Product Code: SR112023A5910

Market Overview:

The global pharmaceutical fine chemicals market size reached US$ 132.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 195.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.42% during 2023-2028.

Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.

Pharmaceutical Fine Chemicals Market Trends:

The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product, size and application.

Breakup by Type:

  • Proprietary
  • Non-proprietary

Breakup by Product:

  • Active Ingredients
  • Basic Building Blocks
  • Advanced Intermediates

Breakup by Size:

  • Big Molecules
  • Small Molecules

Breakup by Application:

  • Cardiovascular
  • Neurological
  • Oncological
  • Respiratory
  • Gastrointestinal
  • Musculoskeletal
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).

Key Questions Answered in This Report:

  • How has the global pharmaceutical fine chemicals market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the size?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical fine chemicals market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Pharmaceutical Fine Chemicals Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Type

  • 6.1  Proprietary
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Non-proprietary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Active Ingredients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Basic Building Blocks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Advanced Intermediates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Size

  • 8.1  Big Molecules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Small Molecules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Cardiovascular
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Neurological
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Oncological
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Respiratory
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Gastrointestinal
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6  Musculoskeletal
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7  Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Borregaard ASA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3  CHEMADA Industries Ltd. (Turpaz)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Denisco Chemicals Pvt Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5  Dupont De Nemours Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Eastman Chemical Company
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Solvay S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Syntor Fine Chemicals Ltd. (Aceto Corporation)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12  W. R. Grace and Co. (Standard Industries Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmaceutical Fine Chemicals Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Fine Chemicals Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Fine Chemicals Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pharmaceutical Fine Chemicals Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Pharmaceutical Fine Chemicals Market: Breakup by Size (in %), 2022
  • Figure 7: Global: Pharmaceutical Fine Chemicals Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Pharmaceutical Fine Chemicals Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Pharmaceutical Fine Chemicals (Proprietary) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pharmaceutical Fine Chemicals (Proprietary) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Pharmaceutical Fine Chemicals (Neurological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Pharmaceutical Fine Chemicals (Neurological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Pharmaceutical Fine Chemicals (Oncological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Pharmaceutical Fine Chemicals (Oncological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Pharmaceutical Fine Chemicals (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Pharmaceutical Fine Chemicals (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Pharmaceutical Fine Chemicals (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Pharmaceutical Fine Chemicals (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Pharmaceutical Fine Chemicals Industry: SWOT Analysis
  • Figure 87: Global: Pharmaceutical Fine Chemicals Industry: Value Chain Analysis
  • Figure 88: Global: Pharmaceutical Fine Chemicals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Fine Chemicals Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Size (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Pharmaceutical Fine Chemicals Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Fine Chemicals Market: Key Players